In recommending measures to manage the contamination of heparin-containing medicines, regulators in the European Union have decided that Sanofi-Aventis’ anticoagulant blockbuster Lovenox should stay ...

Learn more about the benefits and risks of taking Lovenox during pregnancy. While most pregnancies progress smoothly and without serious medical issues, pregnancy usually doesn’t come without some ...

Sanofi-Aventis has turned to the courts in a bid to stop Novartis unit Sandoz and partner Momenta Pharmaceuticals from selling a generic version of its blockbuster anti-clotting drug Lovenox.

Amphastar Pharmaceuticals finally has the FDA's blessing. After a protracted battle marked by lawsuits against the agency and conflicts of interest allegations, the ...

LONDON, June 5 (Reuters) - Doctors in Europe can continue to use Sanofi-Aventis SA's heparin medicine Lovenox, despite low levels of contamination found in some batches of the product, the European ...